Literature DB >> 19712649

Influenza A(H1N1)v in Germany: the first 10,000 cases.

Andreas Gilsdorf1, Gabriele Poggensee.   

Abstract

The analysis of the first 10,000 cases of influenza A(H1N1)v in Germany confirms findings from other sources that the virus is currently mainly causing mild diseases, affecting mostly adolescents and young adults. Overall hospitalisation rate for influenza A(H1N1)v was low (7%). Only 3% of the cases had underlying conditions and pneumonia was rare (0.4%). Both reporting and testing requirements have been adapted recently, taking into consideration the additional information available on influenza A(H1N1)v infections.

Entities:  

Mesh：

Year:  2009        PMID： 19712649     DOI： 10.2807/ese.14.34.19318-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  30 in total

1.  Pandemic influenza A(H1)pdm09 in hospitals and intensive care units - results from a new hospital surveillance, Germany 2009/2010.

Authors:  Cornelia Adlhoch; Maria Wadl; Michael Behnke; Luis Alberto Peña Diaz; Jörg Clausmeyer; Tim Eckmanns
Journal:  Influenza Other Respir Viruses       Date:  2012-07-13       Impact factor: 4.380

2.  Differences in the epidemiological characteristics and clinical outcomes of pandemic (H1N1) 2009 influenza, compared with seasonal influenza.

Authors:  Kevin T Shiley; Gregory Nadolski; Timothy Mickus; Neil O Fishman; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2010-07       Impact factor: 3.254

Review 3.  Influenza susceptibility, severity, and shedding in HIV-infected adults: a review of the literature.

Authors:  Anandi N Sheth; Keri N Althoff; John T Brooks
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

Review 4.  Epidemiological aspects of 2009 H1N1 influenza: the accumulating experience from the Northern Hemisphere.

Authors:  M E Falagas; N V Cholevas; A M Kapaskelis; E K Vouloumanou; A Michalopoulos; P I Rafailidis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-13       Impact factor: 3.267

5.  Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: clinical and economic impact.

Authors:  Sylvie Deuffic-Burban; Xavier Lenne; Benoit Dervaux; Xavier Lemaire; Caroline Sloan; Fabrice Carrat; Jean-Claude Desenclos; Jean-Francois Delfraissy; Yazdan Yazdanpanah
Journal:  PLoS Curr       Date:  2009-10-26

Review 6.  Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.

Authors:  David Reddy
Journal:  J Antimicrob Chemother       Date:  2010-04       Impact factor: 5.790

7.  Diagnostic approach for the differentiation of the pandemic influenza A(H1N1)v virus from recent human influenza viruses by real-time PCR.

Authors:  Martin Schulze; Andreas Nitsche; Brunhilde Schweiger; Barbara Biere
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

Authors:  J S Nguyen-Van-Tam; P J M Openshaw; A Hashim; E M Gadd; W S Lim; M G Semple; R C Read; B L Taylor; S J Brett; J McMenamin; J E Enstone; C Armstrong; K G Nicholson
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

9.  Pandemic and post-pandemic influenza A (H1N1) seasons in a tertiary care university hospital-high rate of complications compared to previous influenza seasons.

Authors:  S Bauernfeind; T Bruennler; B Ehrenstein; J Langgartner; J J Wenzel; S Werner; M Lubnow; T Mueller; B Floerchinger; B Salzberger
Journal:  Infection       Date:  2012-08-11       Impact factor: 3.553

10.  Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

Authors:  Jesus F Bermejo-Martin; Raul Ortiz de Lejarazu; Tomas Pumarola; Jordi Rello; Raquel Almansa; Paula Ramírez; Ignacio Martin-Loeches; David Varillas; Maria C Gallegos; Carlos Serón; Dariela Micheloud; Jose Manuel Gomez; Alberto Tenorio-Abreu; María J Ramos; M Lourdes Molina; Samantha Huidobro; Elia Sanchez; Mónica Gordón; Victoria Fernández; Alberto Del Castillo; Ma Angeles Marcos; Beatriz Villanueva; Carlos Javier López; Mario Rodríguez-Domínguez; Juan-Carlos Galan; Rafael Cantón; Aurora Lietor; Silvia Rojo; Jose M Eiros; Carmen Hinojosa; Isabel Gonzalez; Nuria Torner; David Banner; Alberto Leon; Pablo Cuesta; Thomas Rowe; David J Kelvin
Journal:  Crit Care       Date:  2009-12-11       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.